Prestige Biologics Co., Ltd. (KOSDAQ: 334970)
South Korea
· Delayed Price · Currency is KRW
4,810.00
+10.00 (0.21%)
Jan 22, 2025, 9:00 AM KST
Prestige Biologics Ratios and Metrics
Market cap in millions KRW. Fiscal year is July - June.
Millions KRW. Fiscal year is Jul - Jun.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Jan '25 Jan 21, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 372,379 | 245,391 | 272,542 | 184,546 | 453,181 | - | |
| Market Cap Growth | 98.29% | -9.96% | 47.68% | -59.28% | - | - | |
| Enterprise Value | 441,007 | 378,645 | 369,331 | 283,846 | 447,789 | - | |
| Last Close Price | 4810.00 | 3990.00 | 4460.00 | 3020.00 | 9600.00 | - | |
| PS Ratio | 185.74 | 113.13 | 156.11 | 11855.95 | 140.44 | - | |
| PB Ratio | 2.40 | 3.42 | 2.73 | 1.57 | 4.24 | - | |
| P/TBV Ratio | 2.37 | 3.46 | 2.76 | 1.58 | 4.31 | - | |
| EV/Sales Ratio | 276.18 | 174.57 | 211.55 | 18235.34 | 138.77 | - | |
| Debt / Equity Ratio | 0.68 | 2.41 | 1.60 | 1.01 | 0.73 | -19.80 | |
| Asset Turnover | - | 0.01 | - | 0.00 | 0.03 | - | |
| Inventory Turnover | - | 0.89 | - | 0.00 | 0.14 | 0.00 | |
| Quick Ratio | 0.32 | 0.34 | 0.53 | 0.54 | 1.59 | 0.10 | |
| Current Ratio | 0.70 | 0.60 | 0.79 | 0.92 | 1.93 | 0.17 | |
| Return on Equity (ROE) | - | -34.26% | - | -44.30% | -74.70% | -226.09% | |
| Return on Assets (ROA) | - | -7.02% | - | -9.85% | -13.05% | -23.09% | |
| Return on Capital (ROIC) | - | -8.28% | - | -10.87% | -15.88% | -34.78% | |
| Earnings Yield | -8.58% | -11.97% | -14.47% | -26.94% | -8.69% | - | |
| FCF Yield | -6.37% | -6.87% | -22.11% | -64.36% | -27.17% | - | |
| Buyback Yield / Dilution | -19.15% | -4.43% | -13.35% | -16.43% | -25.46% | -11.46% | |
| Total Shareholder Return | -19.15% | -4.43% | -13.35% | -16.43% | -25.46% | -11.46% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.